HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gerald G Krueger Selected Research

Nail Diseases (Nail Disease)

12/2012A Delphi Consensus Approach to Challenging Case Scenarios in Moderate-to-Severe Psoriasis: Part 1.
4/2009Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebo-controlled study.
5/2007Consensus on a core set of domains for psoriatic arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gerald G Krueger Research Topics

Disease

70Psoriasis (Pustulosis Palmaris et Plantaris)
11/2021 - 04/2002
23Psoriatic Arthritis
02/2016 - 04/2002
5Neoplasms (Cancer)
12/2014 - 10/2004
4Infections
12/2014 - 10/2004
3Inflammation (Inflammations)
04/2021 - 04/2002
3Ankylosing Spondylitis
08/2014 - 04/2009
3Nail Diseases (Nail Disease)
12/2012 - 05/2007
3Rheumatoid Arthritis
02/2010 - 04/2002
2Pain (Aches)
02/2016 - 08/2014
2Cardiovascular Diseases (Cardiovascular Disease)
12/2014 - 07/2009
2Skin Neoplasms (Skin Cancer)
12/2014 - 02/2012
2Fatigue
08/2014 - 05/2007
2Necrosis
11/2013 - 01/2013
2Arthritis (Polyarthritis)
10/2013 - 05/2007
2Virus Diseases (Viral Diseases)
01/2012 - 07/2009
2Hyperpigmentation
02/2005 - 03/2002
1Genetic Risk Score
01/2017
1Back Pain (Backache)
08/2014
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
12/2012
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2012
1Hepatitis B
01/2012
1Disease Susceptibility (Diathesis)
02/2010
1Asthma (Bronchial Asthma)
12/2009
1Liver Diseases (Liver Disease)
07/2009
1Latent Tuberculosis
07/2009
1Crohn Disease (Crohn's Disease)
04/2009
1Liver Cirrhosis (Hepatic Cirrhosis)
07/2008
1Tuberculosis (Tuberculoses)
01/2008
1Spinal Diseases (Disease, Spinal)
05/2007
1Atopic Dermatitis (Atopic Eczema)
02/2007
1Obesity
12/2005

Drug/Important Bio-Agent (IBA)

9CytokinesIBA
11/2021 - 04/2002
9Alefacept (Amevive)FDA Link
01/2008 - 04/2002
7Etanercept (Enbrel)FDA Link
01/2018 - 12/2003
7golimumabFDA Link
02/2016 - 04/2009
6Ustekinumab (CNTO 1275)FDA Link
11/2021 - 05/2008
6Biological ProductsIBA
08/2015 - 10/2004
6Methotrexate (Mexate)FDA LinkGeneric
12/2014 - 06/2004
5Interleukin-13IBA
06/2015 - 04/2009
5Interleukin-12 (IL 12)IBA
02/2012 - 02/2007
4Interleukin-23 (Interleukin 23)IBA
04/2021 - 02/2009
4Prostaglandins AIBA
01/2018 - 09/2009
4HLA-C Antigens (HLA-C)IBA
12/2015 - 10/2008
4Infliximab (Remicade)FDA Link
12/2014 - 11/2006
4Monoclonal AntibodiesIBA
02/2012 - 02/2007
3C-Reactive ProteinIBA
09/2014 - 10/2013
3Biomarkers (Surrogate Marker)IBA
01/2013 - 02/2010
3NF-kappa B (NF-kB)IBA
05/2012 - 02/2009
3Pharmaceutical PreparationsIBA
02/2012 - 08/2003
3Tumor Necrosis Factor InhibitorsIBA
01/2012 - 04/2002
3tazarotene (Tazorac)FDA Link
02/2005 - 05/2003
2InterleukinsIBA
04/2021 - 05/2008
2Proteins (Proteins, Gene)FDA Link
11/2017 - 01/2013
2P-2 (P 2)IBA
01/2017 - 11/2010
2ametantrone (HAQ)IBA
02/2016 - 04/2009
2AcitretinFDA Link
12/2014 - 04/2003
2Adalimumab (Humira)FDA Link
12/2014 - 04/2012
2Cyclosporine (Ciclosporin)FDA LinkGeneric
12/2014 - 01/2008
2Cytokine Receptors (Cytokine Receptor)IBA
03/2010 - 04/2009
2HLA-C*06 antigenIBA
03/2010 - 04/2009
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2009 - 04/2002
2efalizumab (Raptiva)FDA Link
01/2008 - 01/2004
2RetinoidsIBA
01/2008 - 03/2002
2Adrenal Cortex Hormones (Corticosteroids)IBA
12/2005 - 05/2002
1Dihydrotachysterol (AT 10)IBA
11/2021
1Abatacept (Orencia)FDA Link
11/2021
1Interleukin-17 (Interleukin 17)IBA
04/2021
1Genetic Markers (Genetic Marker)IBA
10/2018
1InterferonsIBA
01/2017
1MicroRNAs (MicroRNA)IBA
02/2016
1omega-Chloroacetophenone (Mace)IBA
12/2014
1O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA
08/2014
1Apolipoprotein C-IIIIBA
01/2013
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2013
1AdiponectinIBA
01/2013
1briakinumabIBA
02/2012
1IFIH1 Interferon-Induced HelicaseIBA
12/2010
1UbiquitinIBA
03/2010
1Ligases (Synthetase)IBA
03/2010
1beta-DefensinsIBA
03/2010
1HLA Antigens (Human Leukocyte Antigens)IBA
08/2009
1HLA-B Antigens (HLA-B)IBA
08/2009
1HLA-B57 antigenIBA
08/2009
1Interleukin-15 (Interleukin 15)IBA
04/2009
1Interleukin-4 (Interleukin 4)IBA
10/2008
1Collagen Type III (Type III Collagen)IBA
07/2008
1Antinuclear AntibodiesIBA
01/2008
1Tuberculin (PPD)IBA
01/2008
16-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
01/2008
1Rheumatoid FactorIBA
05/2007
1Acute-Phase Proteins (Acute-Phase Protein)IBA
05/2007
1Tacrolimus (Prograf)FDA LinkGeneric
02/2007
1Interleukin-12 Subunit p40IBA
02/2007
1Ointments (Pastes)IBA
02/2007
1AntibodiesIBA
12/2005

Therapy/Procedure

29Therapeutics
01/2018 - 04/2002
7Phototherapy (Light Therapy)
10/2014 - 04/2003
2Biological Therapy
12/2014 - 01/2008
2Subcutaneous Injections
11/2013 - 04/2009
1Excimer Lasers
01/2012